FemaSys Inc. confirms regained compliance with Nasdaq listing requirements
Femasys Inc. announced it received formal notice from Nasdaq confirming compliance with the bid price rule. This resolves a listing compliance issue and allows the company to maintain its listing while advancing its reproductive health solutions.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day